← Back to Search

Single-Use vs Reusable Duodenoscopes for Biliary and Pancreatic Diseases

N/A
Recruiting
Led By Subhas Banerjee, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age > 18 years old
Patients undergoing ERCP for biliary and pancreatic conditions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial will compare the success and complication rates of two types of endoscopes currently used for a procedure called ERCP.

Who is the study for?
This trial is for adults over 18 who need an ERCP, a special procedure for issues with bile or pancreatic ducts. It's not for pregnant women, those unable to consent, patients with certain infections like CRE or MDRO, or those with complex surgical alterations of the digestive system.Check my eligibility
What is being tested?
The study compares two tools used in ERCP: one is a duodenoscope with a single-use cover and the other is the standard reusable version. The goal is to see which one has better success rates and fewer complications.See study design
What are the potential side effects?
While specific side effects are not listed for this trial, typical risks of ERCP include pancreatitis, infections, bleeding, and perforation of the stomach or intestines.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.
Select...
I am having an ERCP for a bile duct or pancreatic condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with procedure-related adverse events
Secondary outcome measures
Ability to perform interventions
Duodenoscope imaging characteristics profile
Duodenoscope maneuverability
+1 more

Trial Design

2Treatment groups
Active Control
Group I: Conventional DuodenoscopeActive Control1 Intervention
Patients will undergo ERCP using a conventional duodenoscope
Group II: Duodenoscope with single-use distal coverActive Control1 Intervention
Patients will undergo ERCP using a duodenoscope with a single-use distal cover

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,395 Previous Clinical Trials
17,340,755 Total Patients Enrolled
Subhas Banerjee, MDPrincipal InvestigatorStanford University
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have been invited to partcipate in this clinical research?

"Indeed, clinicaltrials.gov data reveals that this research is actively recruiting patients. The trial was first posted on October 25th 2022 and has been updated recently on the 24th of October 2022. 600 participants are being sought at a single medical centre."

Answered by AI

Are there any openings to partake in this trial at present?

"In accordance with clinicaltrials.gov, this trial is actively enlisting participants; the study was posted on October 25th 2022 and its details were updated most recently on October 24th 2022."

Answered by AI
~185 spots leftby Dec 2024